Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...

GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions are ...

When it comes to weight loss, we've all been told that eating a healthy, balanced diet holds the key to success. But for many ...